Proliferation and AKT Activity Biomarker Analyses after Capivasertib (AZD5363) Treatment of Patients with ER+ Invasive Breast Cancer (STAKT)
暂无分享，去创建一个
D. Rea | J. Robertson | K. Cheung | J. Gee | K. Horgan | G. Schiavon | R. Coleman | R. Littleford | P. Rauchhaus | E. D. de Bruin | C. Holcombe | S. Cheung | J. Lindemann | L. Koulai | P. Rugman | A. Evans | A. Skene | P. Finlay | R. Deb | M. Pass | M. Cullberg | A. Jahan | A. Foxley | Samreen Ahmed